Broadwood Partners, L.P.

10% Owner | Director, 10% Owner

3 companies

Insider Signal Score

Good

Trades Analyzed

12M Win Rate

53.8%

Avg 3M Return

-3.0%

Avg 12M Return

+8.3%

Broadwood Partners, L.P. is a Director, 10% Owner at Lineage Cell Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 56 buys and 0 sells.

Estimated insider holdings value: $578.8M based on current market prices.

Holdings by Company

LCTXJan 27, 2025

Current Shares49.56M

Value$63.69M

Net Activity+23.69M

Bought: 23.69MSold: 0

STAAJan 9, 2026

Current Shares15.45M

Value$449.70M

Net Activity+7.71M

Bought: 9.70MSold: 1.99M

IMDXApr 27, 2026

Current Shares12.68M

Value$65.45M

Net Activity+55.67M

Bought: 55.67MSold: 0

Transaction History

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 11, 2024	IMDX Insight Molecular Diagnostics Inc.	10% Owner	Buy	2,420,000	$2.92	$7,057,688.00	+32.5%	+1.9%	-6.2%
Feb 6, 2024	LCTX Lineage Cell Therapeutics, Inc.	Director, 10% Owner	Buy	6,730,770	$1.04	$7,000,000.80	+8.8%	+17.1%	-36.0%
Jan 8, 2024	STAA Staar Surgical Co	10% Owner	Buy	4,042	$27.11	$109,570.13	-	+55.9%	-24.8%
Jan 5, 2024	STAA Staar Surgical Co	10% Owner	Buy	226,553	$28.61	$6,481,556.91	+0.3%	+59.9%	-13.8%
Nov 30, 2023	STAA Staar Surgical Co	10% Owner	Buy	434,991	$31.50	$13,703,830.51	+0.4%	+0.6%	-7.2%
Nov 13, 2023	STAA Staar Surgical Co	10% Owner	Buy	34,827	$32.74	$1,140,132.19	-	-7.7%	-14.6%
Nov 9, 2023	STAA Staar Surgical Co	10% Owner	Buy	289,140	$33.42	$9,662,781.63	+0.4%	-9.3%	-9.5%
Nov 6, 2023	STAA Staar Surgical Co	10% Owner	Buy	309,154	$34.93	$10,797,514.02	+0.4%	-19.8%	-13.0%
Oct 6, 2023	STAA Staar Surgical Co	10% Owner	Buy	205,296	$37.81	$7,762,465.77	+0.4%	-24.8%	-8.9%
Sep 21, 2023	STAA Staar Surgical Co	10% Owner	Buy	291,383	$40.12	$11,689,353.91	+0.5%	-21.4%	-22.8%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC